Use of haemostatic matrix in management of rectus hematoma in an anticoagulated patient: a case report by Kizilkanat, Kansav Tunc et al.
Case report
Open Access
Use of haemostatic matrix in management of rectus hematoma in
an anticoagulated patient: a case report
Kansav Tunc Kizilkanat, Engin Olcucuoglu and Hakan Kulacoglu*
Address: Department of Surgery, Diskapi Yildirim Beyazit Teaching and Research Hospital, Ankara, Turkey
Email: KTK - tunckizilkanat@yahoo.com; EO - drengin@gmail.com; HK* - hakankulacoglu@hotmail.com
*Corresponding author
Received: 3 March 2009 Accepted: 11 June 2009 Published: 7 July 2009
Cases Journal 2009, 2:6353 doi: 10.4076/1757-1626-2-6353
This article is available from: http://casesjournal.com/casesjournal/article/view/6353
© 2009 Kizilkanat et al; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Rectus sheath hematoma may present as a painful mass in the anterior abdominal wall. The underlying
reasons may vary, while anticoagulant use and thromboembolism prophylaxis are documented
causes. Treatment is mostly conservative however interventional procedures can be required. We
herein present a case of 76-year-old patient with an uncontrolled rectus hematoma despite surgical
hemostasis. The patient was treated succesfully by applying hemostatic matrix (Floseal).
Introduction
Rectus sheath hematoma may present as a painful lesion
with or without a visible mass on the anterior abdominal
wall. The underlying reasons may vary. Etiology may
consist of any kind of trauma including abdominal surgery
or even a strenuous cough [1]. Oral anticoagulant usage
and thromboembolism prophylaxis with heparins are also
well-documented causes of rectus sheath hematoma [2].
The treatment of rectus sheath hematoma is conservative
in many cases [2-5] however interventional procedures can
be required in some cases [4,5].
Case presentation
A 76-year-old retired Caucasian Turkish male patient
admitted to the emergency department with a rapid onset
painful mass in the abdominal wall. The mass was in
15 cm in diameter and very tender on physical examina-
tion, and computed tomography displayed a 10 ¥ 5 cm.
hematoma (Figure 1). Hemoglobin level was 14.2 gm and
hematocrit 42.8%. Patient’s history revealed oral antic-
oagulant use [Acetylsalicylate 300 tablet daily] after
a successful coronary by-pass surgery 10 years ago and
cardiac pacemaker placement 2 years ago. Surgical
exploration via a vertical incision over the mass under
general anesthesia in the emergency operating room
displayed a large and expanding rectus muscle hematoma.
Hemostasis was applied with compression and ligation.
The incision was closed after leaving a suction drain
in situ.
Thepatientdevelopedalargerightlumbarecchymosiswhile
daily drainage volume remained 150-200 ml (Figure 2).
Hemoglobin level dropped to 8.9 g and hematocrit to
26.6%. He was still complaining of considerable pain in
spiteofmedications.Are-explorationwasdecidedonday-5.
Previous incision was re-opened with local anesthetic
infiltration. A pulsatile hemorrhage was seen from an
approximately 1-mm vessel. Despite this vessel was ligated
the hemorrhage kept continuing. The operating team
concluded to try hemostatic matrix [FloSeal®, Baxter] for
definitive hemostasis. After applying this novel hemostatic
agent the bleeding stopped (Figure 3).
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the right side of the abdominal wall; possible rectus hematoma.
Figure 2. Continuing hemorrhagic drainage and a massive
ecchymosisonrightsideinspiteofprimary surgicalhemostatis.
Figure 3. (A) Re-exploration and initial aspiration of the field: rectus muscle were torn to display posterior sheet. (B)
Immediate re-bleeding. (C) Application of hemostatic matrix after preparation. (D) Granules covered the cavity to stop bleeding.
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Ecchymosis started to fade away. Patient complained no
pain. Drain was removed after 48 hours and the patient
was discharged. Control examinations on 3, 7, and 15 day
after were completely alright.
Discussion
The treatment of rectus sheath hematoma is mostly
conservative [1-4] however surgical interventions includ-
ing laparotomy [5] or endovascular embolizations have
been reported in patients develop clinical deterioration
[4]. This is especially the case for some patients on
anticoagulant use which may cause life-threatening
abdominal wall hematomas especially when concomitant
systemic disorders also exist [2].
The novel agent FloSeal consists of a bovine-derived
gelatin matrix component and a human-derived thrombin
component. It works on wet, actively bleeding tissue and
conforms to irregular wound surfaces (Figure 4). It has
been proven to control bleeding from oozing to pulsatile
flow [6]. Like the other exogenous hemostatic agents
Floseal are finding increased applications in surgery.
Following its first clinical use reported in 2000 from
United States, the spectrum has been enlarged from case
reports in different disciplines [7,8] to randomized
controlled studies in otolaryngology [9,10].
The use of hemostatic matrix in general surgery field is
rather limited with sporadic applications in patients
suffered abdominal traumas [11]. Very recently, Izzo
et al. reported a large prospective study of 237 consecutive
patients undergoing major hepatic surgery and stated that
the application of a hemostatic matrix provided rapid and
effective intraoperative control of mild to severe bleeding
from the liver edge, even in patients with prolonged
Figure 4. Mechanism of action in direct application.
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our knowledge no report has been published to date about
the use of hemostatic matrix in rectus muscle hematoma
or other abdominal wall injuries. Regarding in-muscle
tissue experience, there is only one report describing the
use of this matrix in successful repair of iatrogenic
diaphragmatic injury during laparoscopy instead of a
formal suture repair [13]. It has been shown experimen-
tally that hemostatic matrix has no adverse effect on the
function of the neurovascular bundles [14]. This may be a
clue for its safe use in muscles which need an intact
neurovascular supply.
In fact, hemostatic matrix is a quite expensive commercial
material. It is more logical to use it in major surgical
procedures and acute life-threatening hemorrhages.
However its application may also be valuable and in
some moderately critical patients with severe concomitant
diseases and coagulation disorders to avoid long hospital
stays, longer immobilization and higher in-hospital
care cost.
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